Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Surg Res. 2014 Feb 22;190(1):344–357. doi: 10.1016/j.jss.2014.02.030

Gene Expression in Fetal Murine Keratinocytes and Fibroblasts

Michael S Hu 1,2, Michael Januszyk 1, Wan Xing Hong 1,3,4, Graham G Walmsley 1, Elizabeth R Zielins 1, David A Atashroo 1, Zeshaan N Maan 1, Adrian McArdle 1, Danny M Takanishi Jr 2, Geoffrey C Gurtner 1, Michael T Longaker 1, H Peter Lorenz 1
PMCID: PMC4113470  NIHMSID: NIHMS585374  PMID: 24726057

Abstract

Background

Early fetuses heal wounds without the formation of a scar. Many studies have attempted to explain this remarkable phenomenon. However, the exact mechanism remains unknown. Herein, we examine the predominant cell types of the epidermis and dermis—the keratinocyte and fibroblast—during different stages of fetal development to better understand the changes that lead to scarring wound repair versus regeneration.

Materials and Methods

Keratinocytes and fibroblasts were harvested and cultured from the dorsal skin of time-dated BALB/c fetuses. Total RNA was isolated and microarray analysis was performed using chips with 42,000 genes. Significance analysis of microarrays (SAM) was utilized to select genes with greater than 2-fold expression differences with a false discovery rate (FDR) of less than 2. Enrichment analysis was performed on significant genes to identify differentially expressed pathways.

Results

By comparing the gene expression profile of keratinocytes from E16 versus E18 fetuses, we identified 24 genes that were downregulated at E16. Analysis of E16 and E18 fibroblasts revealed 522 differentially expressed genes. Enrichment analysis showed the top 20 signaling pathways that were downregulated in E16 keratinocytes and upregulated or downregulated in E16 fibroblasts.

Conclusions

Our data reveal 546 differentially expressed genes in keratinocytes and fibroblasts between the scarless and scarring transition. Additionally, a total of 60 signaling pathways have been identified to be either upregulated or downregulated in these cell types. The genes and pathways recognized by our study may prove to be essential targets that may discriminate between fetal wound regeneration and adult wound repair.

Keywords: Wound healing, Scarless repair, Regeneration, Microarray

Introduction

In 1979 a landmark paper reported that early human fetuses are able to heal wounds without the appearance of a scar (1): whereas scar formation is a physiological process in adult skin and postnatal skin responds to injury with a fibrotic repair process to form scar, embryonic tissue responds with scarless skin regeneration (2). Since then, a number of original articles have attempted to unveil the biological mechanisms underlying this remarkable phenomenon. While the key pathways responsible remain unclear, these studies successfully uncovered a number of important differences between embryonic and adult tissues, all of which may contribute to the observed differences in wound healing. For instance, fetal skin and wounds have been found to differ in terms of both extracellular matrix makeup and response to inflammation (3). In addition, fetal wound research has demonstrated that early to midgestational fetal cutaneous wounds undergo complete scarless regeneration across a number of mammalian species, as well as in ex vivo models (46). In mice, wounds up to 1.5 mm in size at a gestational age 16.5 days (E16.5) or younger have been shown to heal scarlessly with normal restitution of the extracellular matrix and demonstrable regeneration of dermal appendages (7). While this ability to heal scarlessly has been attributed to a variety of intrinsic factors within fetal tissue, no specific cytokines, factors, or cells, however, have yet been identified to be the major driving force for this regeneration.

In order to identify the unknown mediators of fetal regeneration, we performed microarray transcriptional profiling on fetal and postnatal keratinocytes and fibroblasts harvested from E16 and E18 murine fetuses to detect transcriptome differences that occur during scarless versus scarring repair. Fibroblasts were chosen due to their role as prominent sources of connective tissue crucial in both the proliferative and remodeling phases of wound healing (8), and keratinocytes for their ability to regulate the development of fibrosis in the skin (9). Using microarray analysis we found a number of genes with differential transcription in E16 versus E18 cells and mapped them to integrated gene networks via functional genomics. This enabled the identification of relevant pathways that are potential targets for inducing regenerative-type repair with improved collagen architecture and potential epidermal appendage restoration in the postnatal scarring wound.

Materials and Methods

Animals

Six-week-old wild-type BALB/c mice were purchased from Charles River Laboratories (Wilmington, MA). For timed gestations, the mice were bred overnight and the day of vaginal plug was considered E0.5 day of gestation. Animals were maintained in the Stanford Animal Care Laboratory and all procedures were conducted in accordance with university-approved protocols according to National Institutes of Health guidelines.

Primary Cell Culture

Pregnant mice at gestational age E16.5 and E18.5 were euthanized using CO2 and cervical dislocation. Fetal mice were then removed from uteri. Dorsal skin was collected using a dissecting microscope under sterile conditions. In order to obtain sufficient cells to achieve primary culture, skin from E16.5 (n = 10) and postnatal day E18.5 mice (n = 10) was pooled for subsequent keratinocyte and fibroblast harvest.

For keratinocyte primary cell culture, tissue was incubated in defined keratinocyte-SFM (serum-free media) (Gibco Life Technologies, Carlsbad, CA) with 5 mg/mL dispase (BD Biosciences, San Jose, CA) and 10X antibiotic-antimycotic (Gibco Life Technologies) at 4 degrees for 7 hours. Skin was then cut and treated with 0.25% trypsin for 10 min. The cells were subsequently seeded in keratinocyte-SFM.

For fibroblast primary cell culture, tissue was minced and treated with 0.25% trypsin/EDTA in 37 degrees with gentle agitation for 10 min. Cells were plated with mouse embryonic fibroblast (MEF) culture medium consisting of DMEM (Dulbecco’s Modified Eagle Medium), GlutaMAX Supplement (Gibco Life Technologies), 10% fetal bovine serum (Omega Scientific, Tarzana, CA), 0.1 mM 2-mercaptoethanol (Sigma, St. Louis, MO), and 1% penicillin/streptomycin (Gibco Life Technologies).

Keratinocytes and fibroblasts were kept at 37°C in a humid incubator with 5% CO2. Passage one keratinocytes and fibroblasts from both male and female fetuses were used for all experiments.

RNA Extraction and Amplification

RNA from keratinocytes and fibroblasts was extracted using the Trizol protocol (Invitrogen, Carlsbad, CA) per manufacturer’s instructions. One microgram of RNA from each experimental sample was amplified using the MessageAmp aRNA kit (Ambion, Austin, TX). At the same time, 1 µg aliquots of universal mouse RNA were amplified in individual reaction mixtures and utilized as an internal amplification control to allow comparisons between different arrays.

Preparation of Fluorescent cDNA Probes

Four micrograms of RNA and 2 µg of random hexamer were heated at 65°C for 10 minutes and reverse transcribed in a 30 µL total reaction volume containing 2 mM of each deoxyribose nucleotide triphosphate, 1X first-strand buffer, 0.5 µL RNAse inhibitor, 200 U superscript II, 10 mM dithiolthretol, and 3 µL Cy3-deoxyribose uridine triphosphate (dUTP) (for experimental samples) or Cy5-dUTP (for universal mouse control samples) at 42°C for 1 hour. An additional 200 U superscript II was added to boost the reaction and incubated for 1 hour at 42°C. Fluorescent Cy3- or Cy5-labeled probes were washed with TE buffer (10 mM tris, 1 mM EDTA) through a microcon mini column (Millipore, Billerica, MA), concentrated with 450 µL TE buffer, and recovered by spinning the inverted mini column into a fresh tube. Probes were immediately hybridized to microarray chips.

Pretreatment of Microarray Chips

Mouse microarray chips were printed in the Stanford Microarray Database Center with 42,000 specific cDNAs printed onto each lysine-coated slide. These cDNAs represent single accession numbers from Genbank. Sequences and accession numbers of the cDNAs can be found on http://genome-www5.stanford.edu//index.shtml. Before hybridization, microarray chips were first rehydrated (held face down briefly over boiling distilled water) and then snap-dried on a 100°C heating block for 5–10 seconds. DNA was then cross-linked using an ultraviolet cross-linker (300 mJ).

Microarray Hybridization

After heating at 100°C for 2 minutes, fluorescent-labeled probes were denatured and subsequently incubated at 37°C for 20 minutes. A hybridization mixture containing 32 µL of the recovered probe, 6.8 µL of 20X saline sodium citrate (SSC), and 1.2 µL of 10% sodium dodecyl sulfate (SDS) was dropped onto prewarmed microarray slides, and a cover slip applied. Slides were then placed in a sealed moisture chamber for 16 hours at 65°C for hybridization. Following this step, slides were immediately washed once with 1X SSC with 0.03% SDS, twice with 0.5% SSC, and twice with 0.06% SSC. After washing, slides were centrifuged at 84 x g for 2 minutes and scanned immediately using an Axon microarray scanner (Molecular Devices, Sunnyvale, CA).

Microarray Data Analysis

Scanned images were analyzed using the Genepix Pro 4.0 software (Molecular Devices). The densitometry data was up-loaded into the Stanford Microarray Database for gene identification and analysis. The log (base 2) of red/green normalized ratio (mean) was found and the data filtered based on a regression correlation of 0.6. Individual genes and arrays were centered by median. Genes were included in the analysis if they passed the filter criterion of >80% good data and subsequently clustered using Pearson correlation.

Following gene clustering, significance analysis of microarrays (SAM) was used to select genes with significant expression differences between the E16 and E18 transcriptomes for each time point. SAM identifies statistically significant changes in gene expression through the assimilation of a set of gene-specific t tests. Each gene is assigned a score based on its change in expression relative to the standard deviation of repeated measurements for that gene. SAM uses permutations of the repeated measurements to estimate the false discovery rate (FDR), equivalent to chance, for those genes. Genes that had at least a 2-fold expression difference with FDR less than 2 were selected.

Functional Analysis of Differentially Expressed Genes

To identify functional connections among significantly regulated genes, both network and pathway analyses of the probes filtered by microarray were performed as previously described by Jovov et al., using Ingenuity Pathways Analysis (IPA; www.ingenuity.com, Ingenuity Systems, Redwood City, CA). The significance of networks was calculated by IPA’s integrated Ingenuity algorithm, which calculates p-values based on the right-tailed Fisher’s exact test for each canonical pathway, evaluating the likelihood that the association between a subset of genes from the whole experimental data set and a related function/pathway is due to random association.

Results

Differential Gene Expression Between Scarless E16 and Scarring E18 Keratinocytes and Fibroblasts

Transcriptomes from E16 keratinocytes and fibroblasts were directly compared to transcriptomes from E18 keratinocytes and fibroblasts. SAM identified 546 genes differentially expressed with greater than 2-fold difference between E16 and E18 keratinocytes and fibroblasts. Of these 546 genes, for keratinocytes, 24 genes were found to be downregulated in E16 as compared to E18 (Table 1). For fibroblasts, 198 genes were found to be downregulated in E16 as compared to E18 (Table 2). Conversely, 324 genes were found to be upregulated in E16 fibroblasts in comparison to E18 fibroblasts (Table 3).

Table 1.

Genes downregulated in E16 keratinocytes.

Symbol Gene Name
Srp72 signal recognition particle 72
Tpm2 tropomyosin 2, beta
Por P450 (cytochrome) oxidoreductase
Aco1 aconitase 1
Mrpl35 mitochondrial ribosomal protein L35
Xab2 XPA binding protein 2
Rpl13a ribosomal protein L13A
Dstn destrin
Klraq1 KLRAQ motif containing 1
Ube2s ubiquitin-conjugating enzyme E2S
Gtf2h5 general transcription factor IIH, polypeptide 5
Lphn2 latrophilin 2
Trappc5 trafficking protein particle complex 5
Znrf2 zinc and ring finger 2
Pin1 protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1
Mark2 MAP/microtubule affinity-regulating kinase 2
Fahd2a fumarylacetoacetate hydrolase domain containing 2A
Cd320 CD320 antigen
Pnrc2 Proline-rich nuclear receptor coactivator 2
Rps15a ribosomal protein S15A
Kpna6 karyopherin (importin) alpha 6
Eif3d eukaryotic translation initiation factor 3, subunit D
Snrpg small nuclear ribonucleoprotein polypeptide G
Efna5 ephrin A5

Table 2.

Genes downregulated in E16 fibroblasts.

Symbol Gene Name Symbol Gene Name
Rps29 ribosomal protein S29 Cdk20 cyclin-dependent kinase 20
Gapdh glyceraldehyde-3-phosphate
dehydrogenase
Pcdhg@ protocadherin gamma cluster
Hmgn1 high mobility group
nucleosomal binding domain 1
Sun1 Sad1 and UNC84 domain
containing 1
Lyrm4 LYR motif containing 4 Ilf3 interleukin enhancer binding
factor 3
Dcun1d1 DCN1, defective in cullin
neddylation 1, domain
containing 1 (S. cerevisiae)
Akr1c19 aldo-keto reductase family 1,
member C19
Fkbp1a FK506 binding protein 1a Mphosph8 M-phase phosphoprotein 8
Pfkm phosphofructokinase, muscle Pop5 processing of precursor 5,
ribonuclease P/MRP family (S.
cerevisiae)
Adcy7 adenylate cyclase 7 Mpv17 MpV17 mitochondrial inner
membrane protein
Krt83 keratin 83 Ulk1 Unc-51 like kinase 1 (C.
elegans)
Rrp1 ribosomal RNA processing 1
homolog (S. cerevisiae)
Hspa5 heat shock protein 5
Lrrcc1 leucine rich repeat and coiled-
coil domain containing 1
Pax3 paired box gene 3
Ldb3 LIM domain binding 3 Ubr5 ubiquitin protein ligase E3
component n-recognin 5
Hadh hydroxyacyl-Coenzyme A
dehydrogenase
Sorl1 sortilin-related receptor, LDLR
class A repeats-containing
Gls glutaminase Son Son DNA binding protein
Msi2 Musashi homolog 2
(Drosophila)
Dnajc19 DnaJ (Hsp40) homolog,
subfamily C, member 19
Rbfox2 RNA binding protein, fox-1
homolog (C. elegans) 2
Lyl1 lymphoblastomic leukemia 1
Myo9a myosin IXa Csf2 colony stimulating factor 2
(granulocyte-macrophage)
Cdk4 cyclin-dependent kinase 4 Tmem184a transmembrane protein 184a
Gja1 gap junction protein, alpha 1 Plrg1 pleiotropic regulator 1, PRL1
homolog (Arabidopsis)
Lck lymphocyte protein tyrosine
kinase
Prl8a2 prolactin family 8, subfamily a,
member 2
Rpl37a ribosomal protein L37a Stim1 stromal interaction molecule 1
Sh2b2 SH2B adaptor protein 2 Klhdc10 kelch domain containing 10
Spnb2 spectrin beta 2 2700097O09Rik RIKEN cDNA 2700097O09
gene
Arpp19 cAMP-regulated phosphoprotein
19
Tmx2 thioredoxin-related
transmembrane protein 2
Rela v-rel reticuloendotheliosis viral
oncogene homolog A (avian)
Nip7 nuclear import 7 homolog (S.
cerevisiae)
H2-DMb1 histocompatibility 2, class II,
locus Mb1
Xdh xanthine dehydrogenase
Wfdc5 WAP four-disulfide core
domain 5
Nynrin NYN domain and retroviral
integrase containing
Tyrp1 tyrosinase-related protein 1 Rmnd5a required for meiotic nuclear
division 5 homolog A (S.
cerevisiae)
0610031J06Rik RIKEN cDNA 0610031J06
gene
Ube2b ubiquitin-conjugating enzyme
E2B, RAD6 homology (S.
cerevisiae)
septin 9 Stoml3 stomatin (Epb7.2)-like 3
Grina glutamate receptor, ionotropic,
N-methyl D-aspartate-associated
protein 1 (glutamate binding)
S100a9 S100 calcium binding protein
A9 (calgranulin B)
Mtch1 mitochondrial carrier homolog
(C. elegans)
1 Ing5 inhibitor of growth family,
member 5
Cpt2 carnitine palmitoyltransferase 2 B3galnt2 UDP-GalNAc:betaGlcNAc beta
1,3-galactosaminyltransferase,
polypeptide 2
Ctnnb1 catenin (cadherin associated
protein), beta 1
Rabif RAB interacting factor
Egfl6 EGF-like-domain, multiple 6 Pex11b peroxisomal biogenesis factor
11 beta
Golph3 golgi phosphoprotein 3 Abhd16a abhydrolase domain containing
16A
Tcea1 transcription elongation factor A
(SII) 1
Fkbpl FK506 binding protein-like
Abcb10 ATP-binding cassette, sub-
family B (MDR/TAP), member
10
Calm2 calmodulin 2
Mtbp Mdm2, transformed 3T3 cell
double minute p53 binding
protein
Foxn3 forkhead box N3
Lias lipoic acid synthetase Kdm2b lysine (K)-specific demethylase
2B
2310011J03Rik RIKEN cDNA 2310011J03
gene
Gnpnat1 glucosamine-phosphate N-
acetyltransferase 1
Cyth2 cytohesin 2 Bik BCL2-interacting killer
Eif3h eukaryotic translation initiation
factor 3, subunit H
Pde2a phosphodiesterase 2A, cGMP-
stimulated
Bcl2l2 BCL2-like 2 Rcc2 regulator of chromosome
condensation 2
Tex2 testis expressed gene 2 Cd151 CD151 antigen
Hnrnpa2b1 heterogeneous nuclear
ribonucleoprotein A2/B1
Zfp704 zinc finger protein 704
Tbx15 T-box 15 Sohlh1 spermatogenesis and oogenesis
specific basic helix-loop-helix 1
Maoa monoamine oxidase A Antxr1 anthrax toxin receptor 1
Psmb9 proteasome (prosome,
macropain) subunit, beta type 9
(large multifunctional peptidase
2)
Llph LLP homolog, long-term
synaptic facilitation (Aplysia)
Cdk18 cyclin-dependent kinase 18 Ywhae tyrosine 3-
monooxygenase/tryptophan 5-
monooxygenase activation
protein, epsilon polypeptide
Cd83 CD83 antigen Cdk16 cyclin-dependent kinase 16
Tns4 tensin 4 Adss adenylosuccinate synthetase,
non muscle
Slc38a10 solute carrier family 38, member
10
Fam45a family with sequence similarity
45, member A
Cdc42se1 CDC42 small effector 1 Fastkd2 FAST kinase domains 2
Smurf1 SMAD specific E3 ubiquitin
protein ligase 1
Heatr2 HEAT repeat containing 2
1600002H07Rik RIKEN cDNA 1600002H07
gene
Tpr translocated promoter region
Cpt1a carnitine palmitoyltransferase
1a, liver
Lasp1 LIM and SH3 protein 1
Cartpt CART prepropeptide Car2 carbonic anhydrase 2
Fam82b family with sequence similarity
82, member B
Taf10 TAF10 RNA polymerase II,
TATA box binding protein
(TBP)-associated factor
Tdrd3 tudor domain containing 3 Stx2 syntaxin 2
Galt galactose-1-phosphate uridyl
transferase
Commd10 COMM domain containing 10
Dync1i2 dynein cytoplasmic 1
intermediate chain 2
Lap3 leucine aminopeptidase 3
Ctps2 cytidine 5’-triphosphate synthase
2
Hacl1 2-hydroxyacyl-CoA lyase 1
Naa35 N(alpha)-acetyltransferase 35,
NatC auxiliary subunit
Scp2 sterol carrier protein 2, liver
Dcun1d1 DCN1, defective in cullin
neddylation 1, domain
containing 1 (S. cerevisiae)
Iffo2 intermediate filament family
orphan 2
Acd adrenocortical dysplasia Upf3b UPF3 regulator of nonsense
transcripts homolog B (yeast)
Cisd1 CDGSH iron sulfur domain 1 Lmbr1l limb region 1 like
Btf3l4 basic transcription factor 3-like
4
Tmco1 transmembrane and coiled-coil
domains 1
Golph3l golgi phosphoprotein 3-like Klhl13 kelch-like 13 (Drosophila)
Tbx15 T-box 15 Fbxo15 F-box protein 15
Rprd1a regulation of nuclear pre-mRNA
domain containing 1A
Dnaja1 DnaJ (Hsp40) homolog,
subfamily A, member 1
Cat catalase Mau2 MAU2 chromatid cohesion
factor homolog (C. elegans)
Dclk2 doublecortin-like kinase 2 Ywhah tyrosine 3-
monooxygenase/tryptophan 5-
monooxygenase activation
protein, eta polypeptide
Alx3 aristaless-like homeobox 3 1110008L16Rik RIKEN cDNA 1110008L16
gene
Myl6 myosin, light polypeptide 6,
alkali, smooth muscle and non-
muscle
Rbpms RNA binding protein gene with
multiple splicing
Sra1 steroid receptor RNA activator 1 Tmem38b transmembrane protein 38B
Tmc6 transmembrane channel-like
gene family 6
Plac1l placenta-specific 1-like
Brd7 bromodomain containing 7 Dusp26 dual specificity phosphatase 26
(putative)
Cxcl1 chemokine (C-X-C motif)
ligand 1
Mmp3 matrix metallopeptidase 3
Ap1g1 adaptor protein complex AP-1,
gamma 1 subunit
Cisd2 CDGSH iron sulfur domain 2
St3gal1 ST3 beta-galactoside alpha-2,3-
sialyltransferase 1
Son Son DNA binding protein
Mylk3 myosin light chain kinase 3 2200002K05Rik RIKEN cDNA 2200002K05
gene
Pdk4 pyruvate dehydrogenase kinase,
isoenzyme 4
Krt20 keratin 20
Rtkn rhotekin Fam126a family with sequence similarity
126, member A
Rab11a RAB11a, member RAS
oncogene family
Nynrin NYN domain and retroviral
integrase containing
Epdr1 ependymin related protein 1
(zebrafish)
Smg6 Smg-6 homolog, nonsense
mediated mRNA decay factor
(C. elegans)
Krt83 keratin 83 1700021C14Rik RIKEN cDNA 1700021C14
gene
Pax3 paired box gene 3 Cdc34 cell division cycle 34 homolog
(S. cerevisiae)
9030624J02Rik RIKEN cDNA 9030624J02
gene
Rpl17 ribosomal protein L17
Csnk1g2 casein kinase 1, gamma 2 Rpgrip1 retinitis pigmentosa GTPase
regulator interacting protein 1
Stk30 serine/threonine kinase 30 Ube2v2 ubiquitin-conjugating enzyme
E2 variant 2
Macf1 microtubule-actin crosslinking
factor 1
Apbb2 amyloid beta (A4) precursor
protein-binding, family B,
member 2
Ap3b2 adaptor-related protein complex
3, beta 2 subunit
Crtam cytotoxic and regulatory T cell
molecule
Fubp1 far upstream element (FUSE)
binding protein 1
Pon2 paraoxonase 2
Arrdc3 arrestin domain containing 3 Nudt7 nudix (nucleoside diphosphate
linked moiety X)-type motif 7
Vim vimentin Smg6 Smg-6 homolog, nonsense
mediated mRNA decay factor
(C. elegans)
Limd1 LIM domains containing 1 Ssr2 signal sequence receptor, beta
Fubp1 far upstream element (FUSE)
binding protein 1
Parl presenilin associated, rhomboid-
like
Igfbp5 insulin-like growth factor
binding protein 5
Csnk2a1 casein kinase 2, alpha 1
polypeptide
H2-Q8 histocompatibility 2, Q region
locus 8
Cdk20 cyclin-dependent kinase 20

Table 3.

Genes upregulated in E16 fibroblasts.

Symbol Gene Name Symbol Gene Name
Lpar4 lysophosphatidic acid receptor 4 Bola1 bolA-like 1 (E. coli)
Ankrd17 ankyrin repeat domain 17 Tssk2 testis-specific serine kinase 2
C330019G07Rik RIKEN cDNA C330019G07 gene Grin1 glutamate receptor, ionotropic,
NMDA1 (zeta 1)
Golt1b golgi transport 1 homolog B (S.
cerevisiae)
Asb12 ankyrin repeat and SOCS box-
containing 12
Adprh ADP-ribosylarginine hydrolase Mtdh metadherin
Cstf2t cleavage stimulation factor, 3’ pre-
RNA subunit 2, tau
Ankrd1 ankyrin repeat domain 1 (cardiac
muscle)
Ifrg15 interferon alpha responsive gene Slc27a3 solute carrier family 27 (fatty acid
transporter), member 3
4632428N05Rik RIKEN cDNA 4632428N05 gene Darc Duffy blood group, chemokine
receptor
Gsk3b glycogen synthase kinase 3 beta Ezh1 enhancer of zeste homolog 1
(Drosophila)
Slc35a1 solute carrier family 35 (CMP-sialic
acid transporter), member 1
AU019823 expressed sequence AU019823
Mepce methylphosphate capping enzyme Hist1h2ae histone cluster 1, H2ae
Ptges prostaglandin E synthase Bdh2 3-hydroxybutyrate dehydrogenase,
type 2
Slc9a6 solute carrier family 9
(sodium/hydrogen exchanger),
member 6
Mphosph10 M-phase phosphoprotein 10 (U3
small nucleolar ribonucleoprotein)
BC016495 cDNA sequence BC016495 Prkag1 protein kinase, AMP-activated,
gamma 1 non-catalytic subunit
Mocs1 molybdenum cofactor synthesis 1 Lrat lecithin-retinol acyltransferase
(phosphatidylcholine-retinol-O-
acyltransferase)
Pbk PDZ binding kinase Gtf3c6 general transcription factor IIIC,
polypeptide 6, alpha
Ficd FIC domain containing Aasdhppt aminoadipate-semialdehyde
dehydrogenase-phosphopantetheinyl
transferase
Cdc42ep5 CDC42 effector protein (Rho
GTPase binding) 5
Ddx49 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 49
4930528F23Rik RIKEN cDNA 4930528F23 gene Ilk integrin linked kinase
Myo10 myosin X Kcnab3 potassium voltage-gated channel,
shaker-related subfamily, beta
member 3
Coro1a coronin, actin binding protein 1A Krt13 keratin 13
Ppp1r2 protein phosphatase 1, regulatory
(inhibitor) subunit 2
Med11 mediator of RNA polymerase II
transcription, subunit 11 homolog (S.
cerevisiae)
Fank1 fibronectin type 3 and ankyrin repeat
domains 1
Appl1 adaptor protein, phosphotyrosine
interaction, PH domain and leucine
zipper containing 1
S100a11 S100 calcium binding protein A11
(calgizzarin)
B4galt1 UDP-Gal:betaGlcNAc beta 1,4-
galactosyltransferase, polypeptide 1
Zcchc3 zinc finger, CCHC domain
containing 3
5430437P03Rik RIKEN cDNA 5430437P03 gene
Rsph9 radial spoke head 9 homolog
(Chlamydomonas)
Lysmd4 LysM, putative peptidoglycan-
binding, domain containing 4
Tex19.1 testis expressed gene 19.1 Atp4a ATPase, H+/K+ exchanging, gastric,
alpha polypeptide
Ift74 intraflagellar transport 74 homolog
(Chlamydomonas)
Il10rb interleukin 10 receptor, beta
Snap25 synaptosomal-associated protein 25 Dnajc10 DnaJ (Hsp40) homolog, subfamily
C, member 10
Tipin timeless interacting protein 6-Sep septin 6
Rab3a RAB3A, member RAS oncogene
family
Adal adenosine deaminase-like
Foxn2 forkhead box N2 Tpm2 tropomyosin 2, beta
Tmsb15l thymosin beta 15b like Ppp1r9a protein phosphatase 1, regulatory
(inhibitor) subunit 9A
Ppat phosphoribosyl pyrophosphate
amidotransferase
Hspbp1 HSPA (heat shock 70kDa) binding
protein, cytoplasmic cochaperone 1
Rbm34 RNA binding motif protein 34 Scnm1 sodium channel modifier 1
Mllt3 translocated to, 3 Ctnna2 catenin (cadherin associated protein),
alpha 2
Cda cytidine deaminase Hao2 hydroxyacid oxidase 2
Plac9 placenta specific 9 Fam20c family with sequence similarity 20,
member C
Zfp821 zinc finger protein 821 Edn2 endothelin 2
Parp16 poly (ADP-ribose) polymerase
family, member 16
Rhoc ras homolog gene family, member C
Uckl1 uridine-cytidine kinase 1-like 1 Cdkn2b cyclin-dependent kinase inhibitor 2B
(p15, inhibits CDK4)
Cct6a chaperonin containing Tcp1, subunit
6a (zeta)
Dhfr dihydrofolate reductase
Acsl6 acyl-CoA synthetase long-chain
family member 6
Rabac1 Rab acceptor 1 (prenylated)
Tspan31 tetraspanin 31 Scrn1 secernin 1
Spire1 spire homolog 1 (Drosophila) Slc33a1 solute carrier family 33 (acetyl-CoA
transporter), member 1
Phtf2 putative homeodomain transcription
factor 2
Akirin2 akirin 2
Akap13 A kinase (PRKA) anchor protein 13 Wipi2 WD repeat domain, phosphoinositide
interacting 2
Mdh2 malate dehydrogenase 2, NAD
(mitochondrial)
Isoc1 isochorismatase domain containing 1
Mrpl49 mitochondrial ribosomal protein L49 Plekhf2 pleckstrin homology domain
containing, family F (with FYVE
domain) member 2
Efna2 ephrin A2 Tspan3 tetraspanin 3
Mbd4 methyl-CpG binding domain protein
4
Ece2 endothelin converting enzyme 2
Vegfc vascular endothelial growth factor C Hspb7 heat shock protein family, member 7
(cardiovascular)
Wrnip1 Werner helicase interacting protein 1 Atf4 activating transcription factor 4
Pikfyve phosphoinositide kinase, FYVE
finger containing
D19Wsu162e DNA segment, Chr 19, Wayne State
University 162, expressed
Cyba cytochrome b-245, alpha polypeptide Srp14 signal recognition particle 14
Dstyk dual serine/threonine and tyrosine
protein kinase
Il2 interleukin 2
Stmn3 stathmin-like 3 G3bp2 GTPase activating protein (SH3
domain) binding protein 2
Pepd peptidase D Inpp5d inositol polyphosphate-5-
phosphatase D
Chgb chromogranin B Slc30a4 solute carrier family 30 (zinc
transporter), member 4
Thap7 THAP domain containing 7 Mmp14 matrix metallopeptidase 14
(membrane-inserted)
4833439L19Rik RIKEN cDNA 4833439L19 gene Lmbrd1 LMBR1 domain containing 1
Pdgfa platelet derived growth factor, alpha D10Wsu102e DNA segment, Chr 10, Wayne State
University 102, expressed
Pja1 praja1, RING-H2 motif containing Dock7 dedicator of cytokinesis 7
Car10 carbonic anhydrase 10 Camp cathelicidin antimicrobial peptide
Trmt2a TRM2 tRNA methyltransferase 2
homolog A (S. cerevisiae)
Usp39 ubiquitin specific peptidase 39
Stat1 signal transducer and activator of
transcription 1
Ints4 integrator complex subunit 4
Trappc5 trafficking protein particle complex 5 Senp6 SUMO/sentrin specific peptidase 6
Zmat5 zinc finger, matrin type 5 Csnk2b casein kinase 2, beta polypeptide
1700012B15Rik RIKEN cDNA 1700012B15 gene Hras1 Harvey rat sarcoma virus oncogene 1
Dpep1 dipeptidase 1 (renal) Med19 mediator of RNA polymerase II
transcription, subunit 19 homolog
(yeast)
Zyx zyxin Pgcp plasma glutamate carboxypeptidase
Hpcal1 hippocalcin-like 1 Tmem41b transmembrane protein 41B
Cdk5rap3 CDK5 regulatory subunit associated
protein 3
1700014N06Rik RIKEN cDNA 1700014N06 gene
Ppp3cc protein phosphatase 3, catalytic
subunit, gamma isoform
AI314180 expressed sequence AI314180
Mettl21a methyltransferase like 21A Prpsap1 phosphoribosyl pyrophosphate
synthetase-associated protein 1
Tpd52l1 tumor protein D52-like 1 Gng13 guanine nucleotide binding protein
(G protein), gamma 13
Hoxb2 homeobox B2 Snap23 synaptosomal-associated protein 23
Mobkl2a MOB1, Mps One Binder kinase
activator-like 2A (yeast)
Mpp1 membrane protein, palmitoylated
Txndc16 thioredoxin domain containing 16 Cnot1 CCR4-NOT transcription complex,
subunit 1
Galntl5 UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like
5
Egf epidermal growth factor
Mcm5 minichromosome maintenance
deficient 5, cell division cycle 46 (S.
cerevisiae)
Myo16 myosin XVI
Tinf2 Terf1 (TRF1)-interacting nuclear
factor 2
Gatm glycine amidinotransferase (L-
arginine:glycine amidinotransferase)
Krt19 keratin 19 Krt24 keratin 24
Setd3 SET domain containing 3 Gas5 growth arrest specific 5
Bfar bifunctional apoptosis regulator Zfp318 zinc finger protein 318
Smarcd2 SWI/SNF related, matrix associated,
actin dependent regulator of
chromatin, subfamily d, member 2
Rapgef4 Rap guanine nucleotide exchange
factor (GEF) 4
Il12a interleukin 12a Carkd carbohydrate kinase domain
containing
Agpat3 1-acylglycerol-3-phosphate O-
acyltransferase 3
2210012G02Rik RIKEN cDNA 2210012G02 gene
Myc myelocytomatosis oncogene 1700001J03Rik RIKEN cDNA 1700001J03 gene
Pon1 paraoxonase 1 Uqcrh ubiquinol-cytochrome c reductase
hinge protein
Slc44a3 solute carrier family 44, member 3 Sult1d1 sulfotransferase family 1D, member
1
Ccr5 chemokine (C-C motif) receptor 5 Paqr5 progestin and adipoQ receptor family
member V
Pex19 peroxisomal biogenesis factor 19 Syvn1 synovial apoptosis inhibitor 1,
synoviolin
Gadd45g growth arrest and DNA-damage-
inducible 45 gamma
Cox17 cytochrome c oxidase, subunit XVII
assembly protein homolog (yeast)
1700028P14Rik RIKEN cDNA 1700028P14 gene Crym crystallin, mu
Cdh3 cadherin 3 Tbl2 transducin (beta)-like 2
Mettl21a methyltransferase like 21A Ogdh oxoglutarate dehydrogenase
(lipoamide)
Cenph centromere protein H Ypel1 yippee-like 1 (Drosophila)
Khdc1b KH domain containing 1B Myl4 myosin, light polypeptide 4
Odz3 odd Oz/ten-m homolog 3
(Drosophila)
D2Ertd750e DNA segment, Chr 2, ERATO Doi
750, expressed
Stab1 stabilin 1 Nme3 non-metastatic cells 3, protein
expressed in
Unkl unkempt-like (Drosophila) Sft2d1 SFT2 domain containing 1
Map1lc3b microtubule-associated protein 1
light chain 3 beta
Wwtr1 WW domain containing transcription
regulator 1
Smurf2 SMAD specific E3 ubiquitin protein
ligase 2
Asb1 ankyrin repeat and SOCS box-
containing 1
Ndufa13 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex, 13
Serpini2 serine (or cysteine) peptidase
inhibitor, clade I, member 2
Rab11fip1 RAB11 family interacting protein 1
(class I)
Elk1 ELK1, member of ETS oncogene
family
Atp7a ATPase, Cu++ transporting, alpha
polypeptide
Nubp1 nucleotide binding protein 1
Fcgbp Fc fragment of IgG binding protein Scaf11 SR-related CTD-associated factor 11
Josd2 Josephin domain containing 2 Acyp1 acylphosphatase 1, erythrocyte
(common) type
Irx5 Iroquois related homeobox 5
(Drosophila)
Rpl10 ribosomal protein 10
Stra13 stimulated by retinoic acid 13 Herc4 hect domain and RLD 4
Gys1 glycogen synthase 1, muscle Fam195b family with sequence similarity 195,
member B
Ccs copper chaperone for superoxide
dismutase
Ubash3b ubiquitin associated and SH3 domain
containing, B
Slc1a5 solute carrier family 1 (neutral amino
acid transporter), member 5
Slc6a1 solute carrier family 6
(neurotransmitter transporter,
GABA), member 1
Ngly1 N-glycanase 1 Angptl1 angiopoietin-like 1
Dcbld1 discoidin, CUB and LCCL domain
containing 1
Wdr54 WD repeat domain 54
Mast2 microtubule associated
serine/threonine kinase 2
Rbbp6 retinoblastoma binding protein 6
Crlf1 cytokine receptor-like factor 1 1190007F08Rik RIKEN cDNA 1190007F08 gene
Asnsd1 asparagine synthetase domain
containing 1
Dll1 delta-like 1 (Drosophila)
Dcun1d5 DCN1, defective in cullin
neddylation 1, domain containing 5
(S. cerevisiae)
Nppb natriuretic peptide type B
Fam185a family with sequence similarity 185,
member A
Nfatc3 nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 3
Hdac11 histone deacetylase 11 Lrch2 leucine-rich repeats and calponin
homology (CH) domain containing 2
1110034A24Rik RIKEN cDNA 1110034A24 gene Atp5b ATP synthase, H+ transporting
mitochondrial F1 complex, beta
subunit
Rps4y2 ribosomal protein S4, Y-linked 2 Rrp12 ribosomal RNA processing 12
homolog (S. cerevisiae)
Zfp868 zinc finger protein 868 Dhx16 DEAH (Asp-Glu-Ala-His) box
polypeptide 16
Psmc2 proteasome (prosome, macropain)
26S subunit, ATPase 2
Dmap1 DNA methyltransferase 1-associated
protein 1
Rbm39 RNA binding motif protein 39 Slc1a4 solute carrier family 1
(glutamate/neutral amino acid
transporter), member 4
Ctnna1 catenin (cadherin associated protein),
alpha 1
Smc4 structural maintenance of
chromosomes 4
Cyth1 cytohesin 1 Camsap1 calmodulin regulated spectrin-
associated protein 1
Sco1 SCO cytochrome oxidase deficient
homolog 1 (yeast)
Cntln centlein, centrosomal protein
Calb1 calbindin 1 Ckap2l cytoskeleton associated protein 2-
like
2310001H18Rik RIKEN cDNA 2310001H18 gene Katna1 katanin p60 (ATPase-containing)
subunit A1
Sh3d19 SH3 domain protein D19 Speg SPEG complex locus
Acadsb acyl-Coenzyme A dehydrogenase,
short/branched chain
Nsdhl NAD(P) dependent steroid
dehydrogenase-like
Map2k2 mitogen-activated protein kinase
kinase 2
Lsm6 LSM6 homolog, U6 small nuclear
RNA associated (S. cerevisiae)
Cd3g CD3 antigen, gamma polypeptide Tgm1 transglutaminase 1, K polypeptide
Sepn1 selenoprotein N, 1 Notch1 Notch gene homolog 1 (Drosophila)
Ndufa3 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex, 3
Ndufa11 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex 11
B3gnt7 UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 7
Srsf3 serine/arginine-rich splicing factor 3
Stat6 signal transducer and activator of
transcription 6
Vps26b vacuolar protein sorting 26 homolog
B (yeast)
Nol4 nucleolar protein 4 Cetn3 centrin 3
Rpl37a ribosomal protein L37a Tprgl transformation related protein 63
regulated like
Lhx6 LIM homeobox protein 6 Tgif2 TGFB-induced factor homeobox 2
Myof myoferlin BC016423 cDNA sequence BC016423
Cox5a cytochrome c oxidase, subunit Va Mycbp2 MYC binding protein 2
Rpl19 ribosomal protein L19 Jak2 Janus kinase 2
Cyth2 cytohesin 2 Metap2 methionine aminopeptidase 2
Chchd3 coiled-coil-helix-coiled-coil-helix
domain containing 3
Myh8 myosin, heavy polypeptide 8,
skeletal muscle, perinatal
Runx1t1 translocated to, 1 (cyclin D-related) Ehd3 EH-domain containing 3
Rpl3 ribosomal protein L3 Jak2 Janus kinase 2
Syf2 SYF2 homolog, RNA splicing factor
(S. cerevisiae)
Lefty1 left right determination factor 1
Cyp26a1 cytochrome P450, family 26,
subfamily a, polypeptide 1
Dynll2 dynein light chain LC8-type 2
Agfg1 ArfGAP with FG repeats 1 Fam57a family with sequence similarity 57,
member A
Pin1 protein (peptidyl-prolyl cis/trans
isomerase) NIMA-interacting 1
Srp72 signal recognition particle 72
Tnfrsf12a tumor necrosis factor receptor
superfamily, member 12a
Snhg11 small nucleolar RNA host gene 11
Ttc4 tetratricopeptide repeat domain 4 Celf4 CUGBP, Elav-like family member 4
G3bp2 GTPase activating protein (SH3
domain) binding protein 2
1810043G02Rik RIKEN cDNA 1810043G02 gene
Tm4sf20 transmembrane 4 L six family
member 20
Zrsr1 zinc finger (CCCH type), RNA
binding motif and serine/arginine
rich 1
Gosr2 golgi SNAP receptor complex
member 2
Il2ra interleukin 2 receptor, alpha chain
Ndufaf1 NADH dehydrogenase (ubiquinone)
1 alpha subcomplex, assembly factor 1
Wnt4 wingless-related MMTV integration
site 4
8030474K03Rik RIKEN cDNA 8030474K03 gene Fam187b family with sequence similarity 187,
member B
Stoml2 stomatin (Epb7.2)-like 2 Bola1 bolA-like 1 (E. coli)

Functional Pathway Analysis

Out of the 24 genes found to be downregulated in E16 keratinocytes (Figure 1A), twenty functional pathways were identified (Figure 1B). The top five pathways were associated with: EIF2 signaling, 1,25-dihydroxyvitamin D3 biosynthesis, regulation of eIF4 and p7056K signaling, Wnt/β-catenin signaling, and RAN signaling.

Figure 1. Microarray analysis of E16 and E18 keratinocytes.

Figure 1

(A) Hierarchical clustering of differentially regulated genes from fetal keratinocytes at E16 vs. E18. Individual genes are clustering according to the dendrogram on the left, and expression levels are represented in the heatmap on the right. Yellow and blue indicate up- and down-regulation, respectively. (B) Canonical pathways significantly enriched for among genes whose expression was significantly downregulated in E16 samples compared to E18.

Of the 198 genes downregulated in E16 fibroblasts compared to E18 fibroblasts (Figure 2A), twenty functional pathways were again identified (Figure 2B). The top five pathways were: endometrial cancer signaling, PDGF signaling, IL-3 signaling, colorectal cancer metastasis signaling and FLT3 signaling in hematopoietic progenitor cells.

Figure 2. Microarray analysis of E16 and E18 fibroblasts.

Figure 2

(A) Hierarchical clustering of differentially regulated genes from fetal fibroblasts at E16 vs. E18. Individual genes are clustering according to the dendrogram on the left, and expression levels are represented in the heatmap on the right. Yellow and blue indicate up- and down-regulation, respectively. (B) Canonical pathways significantly enriched for among genes whose expression was significantly downregulated in E16 samples compared to E18. (C) Canonical pathways significantly enriched for among genes whose expression was significantly upregulated in E16 samples compared to E18.

From the 324 genes found to be upregulated in E16 fibroblasts in comparison to E18 fibroblasts (Figure 2C), the top five functional pathways were associated with: superoxide radicals degradation, protein ubiquination, melanocyte development and pigment signaling, nNOS signaling, and mitochondrial L-carnitine shuttling.

Discussion

Early gestational skin has the unique ability to regenerate following injury. However, during the later stages of fetal development, this ability gradually diminishes, culminating ultimately with an adult cutaneous wound healing process characterized by scarring. The goal of our study is to identify candidate pathways important to scarless wound healing that might be manipulated in adult wound healing to decrease scarring and promote regenerative healing. In order to achieve this goal, we performed microarray analysis on fetal keratinocytes and fibroblasts from fetal scarless and scarring time points. Furthermore, to better understand individual gene expression changes, we performed signal pathway analysis. This technique allowed us to identify gene cascades that are coordinately regulated during the transition period. In this section we will discuss in greater detail some of the especially relevant pathways found to be differentially activated in E16 versus E18 keratinocytes and fibroblasts.

Beta-Catenin Dependent Wnt Signaling

The Wnt family of glycoproteins is involved in proliferation, differentiation, migration, and carcinogenesis (10) as well as in dermal and epidermal maturation (11). Wnt proteins are expressed following cutaneous injury, and different Wnt signaling in response to injury has been found to occur pre- and post-natally. For instance, a 2010 study by Carre et al. revealed that β-catenin–dependent Wnt signaling expression is different between scarless fetal and scarring postnatal wound repair (7). This finding is corroborated by the results of our study. We demonstrated that Wnt signaling pathways are upregulated in nonwounded scarring fetal keratinocytes at E18 in comparison to nonscarring fetal keratinocytes at E16. While other studies in the past have compared Wnt signaling between fetal and adult skin, our study is the first to compare Wnt activation in early and late gestational age nonwounded skin. The differential activation of Wnt signaling pathways between E16 and E18 keratinocytes suggests that Wnt signaling may play an important role in regulating the different wound healing outcomes in early and late gestational skin. Moreover, Wnt is known to positively regulate TGF-β1, a key mediator of fibrosis implicated in hypertrophic scar formation (12, 13), transcription in postnatal skin cells, suggesting a possible mechanism by which upregulation of Wnt signaling in late gestational keratinocytes might contribute to loss of regenerative ability. Taken together, these data suggest that β-catenin–dependent Wnt pathways may be early and key regulators of embryonic wound healing.

PDGF Signaling

Whereas adult wounds are known to contain large quantities of PDGF, this growth factor is virtually absent in embryonic wounds (14). Similarly, a 2003 study by Song et al. found strong expression of PDGF in adult skin but not in unwounded fetal skin (15). However, no previous study has looked specifically at differential activation of PDGF signaling in early regenerative versus late scarring gestational fetal skin. Our functional pathway analysis data demonstrated for the first time increased activation of PDGF in E18 fibroblasts compared to E16 fibroblasts, suggesting an important role for increased PDGF signaling in loss of regenerative ability in late gestational fibroblasts. This finding is supported by published reports that have established a role for PDGF in regulating the proliferation and differentiation of keratinocytes and fibroblasts (16), as well as in upregulation of the expression of profibrotic TGF-β1 receptors (17). Furthermore, fetal wounds have been found to have lower concentrations of inflammatory cells such as neutrophils, which are recruited by PDGF, than adult wounds (2). This may provide a key mechanism for scarless fetal regeneration as neutrophils amplify the inflammatory response in wound beds, contributing to the formation of a scar.

Superoxide Radicals Degradation

Conversely, we found that E16 fibroblasts had upregulation of superoxide radicals degradation in comparison to E18 fibroblasts. During the early inflammatory phase following injury, inflammatory cells invade the wound bed. When active, these cells produce large amounts of reactive oxygen species (ROS) as part of their functional role in the wound healing process (18). While essential to debridement of the wound site, excess ROS can inhibit wound healing and lead to tissue damage. For instance, low levels of antioxidants accompanied by raised levels of markers of free radical damage led to decreased wound healing in aged and diabetic mice (19). Taken together, our findings suggest that enhanced detoxification of ROS may contribute to the regenerative ability of fetal skin.

Conclusion

Using functional pathway analysis, for the first time, we demonstrated differential pathway regulation in scarless and scarring fetal skin cells. Due to the large amount of data generated by both microarray and pathway analysis, we focused our discussion on a few pathways known to be particularly relevant to wound healing. However, our study reveals hundreds of genes and tens of pathways novel to the transition from scarless to scarring repair. We believe that identification of these pathways most likely to be proregenerative or profibrotic provides a valuable starting point for further experimental study aimed at elucidating mechanisms underlying the regenerative ability of early embryonic skin, with possible applications to other organ systems.

Acknowledgements

This work was supported in part by a grant from NIH grant R01 GM087609 (to H.P.L.), a Gift from Ingrid Lai and Bill Shu in honor of Anthony Shu (to H.P.L.), and the Hagey Laboratory for Pediatric Regenerative Medicine and Children’s Surgical Research Program (to M.T.L. and H.P.L.). Additional funding was provided by the Sarnoff Cardiovascular Research Foundation (to W.X.H.).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Author Contributions:

Michael S. Hu: conception and design, data collection, analysis and interpretation, writing the article, critical revision of the article

Michael Januszyk: analysis and interpretation, writing the article, critical revision of the article

Wan Xing Hong: writing the article, analysis and interpretation, critical revision of the article

Graham G. Walmsley: conception and design, analysis and interpretation

Elizabeth R. Zielins: data collection, analysis and interpretation

David A. Atashroo: data collection, analysis and interpretation

Zeshaan N. Maan: data collection, analysis and interpretation

Adrian McArdle: data collection, analysis and interpretation

Danny M. Takanishi: analysis and interpretation, critical revision of the article

Geoffrey C. Gurtner: analysis and interpretation, critical revision of the article

Michael T. Longaker: critical revision of the article, obtaining funding

H. Peter Lorenz: conception and design, analysis and interpretation, critical revision of the article, obtaining funding

The authors have no conflicts of interest to disclose.

References

  • 1.Rowlatt U. Intrauterine wound healing in a 20 week human fetus. Virchows Archiv. A, Pathological anatomy and histology. 1979;381(3):353–361. doi: 10.1007/BF00432477. [DOI] [PubMed] [Google Scholar]
  • 2.Lo DD, Zimmermann AS, Nauta A, Longaker MT, Lorenz HP. Scarless fetal skin wound healing update. Birth defects research. Part C, Embryo today : reviews. 2012;96(3):237–247. doi: 10.1002/bdrc.21018. [DOI] [PubMed] [Google Scholar]
  • 3.Buchanan EP, Longaker MT, Lorenz HP. Fetal skin wound healing. Advances in clinical chemistry. 2009;48:137–161. doi: 10.1016/s0065-2423(09)48006-5. [DOI] [PubMed] [Google Scholar]
  • 4.Lorenz HP, et al. Scarless wound repair: a human fetal skin model. Development. 1992;114(1):253–259. doi: 10.1242/dev.114.1.253. [DOI] [PubMed] [Google Scholar]
  • 5.Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. Fetal wound healing. The ontogeny of scar formation in the non-human primate. Annals of surgery. 1993;217(4):391–396. doi: 10.1097/00000658-199304000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lorenz HP, Adzick NS. Scarless skin wound repair in the fetus. The Western journal of medicine. 1993;159(3):350–355. [PMC free article] [PubMed] [Google Scholar]
  • 7.Carre AL, et al. Interaction of wingless protein (Wnt), transforming growth factor-beta1, and hyaluronan production in fetal and postnatal fibroblasts. Plastic and reconstructive surgery. 2010;125(1):74–88. doi: 10.1097/PRS.0b013e3181c495d1. [DOI] [PubMed] [Google Scholar]
  • 8.Larson BJ, Longaker MT, Lorenz HP. Scarless fetal wound healing: a basic science review. Plastic and reconstructive surgery. 2010;126(4):1172–1180. doi: 10.1097/PRS.0b013e3181eae781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Varkey M, Ding J, Tredget EE. Fibrotic Remodeling of Tissue-Engineered Skin with Deep Dermal Fibroblasts Is Reduced by Keratinocytes. Tissue engineering. Part A. 2013 doi: 10.1089/ten.TEA.2013.0434. [DOI] [PubMed] [Google Scholar]
  • 10.Colwell AS, Krummel TM, Longaker MT, Lorenz HP. Wnt-4 expression is increased in fibroblasts after TGF-beta1 stimulation and during fetal and postnatal wound repair. Plastic and reconstructive surgery. 2006;117(7):2297–2301. doi: 10.1097/01.prs.0000218708.16909.31. [DOI] [PubMed] [Google Scholar]
  • 11.Reddy S, et al. Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis. Mechanisms of development. 2001;107(1–2):69–82. doi: 10.1016/s0925-4773(01)00452-x. [DOI] [PubMed] [Google Scholar]
  • 12.Lu L, et al. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. Journal of the American College of Surgeons. 2005;201(3):391–397. doi: 10.1016/j.jamcollsurg.2005.03.032. [DOI] [PubMed] [Google Scholar]
  • 13.Beanes SR, Dang C, Soo C, Ting K. Skin repair and scar formation: the central role of TGF-beta. Expert reviews in molecular medicine. 2003;5(8):1–22. doi: 10.1017/S1462399403005817. [DOI] [PubMed] [Google Scholar]
  • 14.Ferguson MW, O’Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2004;359(1445):839–850. doi: 10.1098/rstb.2004.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Song HF, et al. [A comparative study of PDGF and EGF expression in skin wound healing between human fetal and adult] Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery. 2003;19(3):199–202. [PubMed] [Google Scholar]
  • 16.Tiede S, et al. Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft. 2009;191(1):33–44. doi: 10.1016/j.aanat.2008.10.001. [DOI] [PubMed] [Google Scholar]
  • 17.Czuwara-Ladykowska J, Gore EA, Shegogue DA, Smith EA, Trojanowska M. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts. The British journal of dermatology. 2001;145(4):569–575. doi: 10.1046/j.1365-2133.2001.04443.x. [DOI] [PubMed] [Google Scholar]
  • 18.Steiling H, Munz B, Werner S, Brauchle M. Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Experimental cell research. 1999;247(2):484–494. doi: 10.1006/excr.1998.4366. [DOI] [PubMed] [Google Scholar]
  • 19.Rasik AM, Shukla A. Antioxidant status in delayed healing type of wounds. International journal of experimental pathology. 2000;81(4):257–263. doi: 10.1046/j.1365-2613.2000.00158.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES